Ortho Regenerative Technologies Receives Clinical Hold Letter From the U.S. FDA

Additional CMC related data and characterization requested by the FDA Company confident of providing requested information over the coming weeks Phase I/II clinical trial preparation activities to continue in preparation of anticipated IND approval. ... Regenerative Medicine, Orthopaedic, FDA Ortho Regenerative Technologies, ORTHO-R
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news